OptiBiotix Health's unflavoured SlimBiome Medical granted medical device status and CE mark

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Life sciences business OptiBiotix Health announced it has achieved medical device status and a CE mark for an unflavoured version of SlimBiome Medical.

It said this provided a product line extension to the existing SlimBiome Medical range which will be launched commercially in the first half of 2020.

Dr Fred Narbel, managing director of OptiBiotix's prebiotics division, said: 'We are very pleased to have been granted a medical device status and a CE mark for the second time over a 12-month period.

'This line extension will help us convert the commercial opportunities we are working on into distribution agreements.'

The company said its decision to launch an unflavoured version of SlimBiome Medical had allowed it to extend its product offering and that, when used in combination with taste enhancement products, such as the 'Natural Flavour Boosters' which launched in the fourth quarter of 2019, expands the choice of flavours available to its customers.

At 9:48am: (LON:OPTI) Optibiotix Health Plc share price was +1.5p at 51.5p